Remodeling of astrocytes, a prerequisite for synapse turnover in the adult brain? Insights from the oxytocin system of the hypothalamus DT Theodosis, A Trailin, DA Poulain American Journal of Physiology-Regulatory, Integrative and Comparative …, 2006 | 85 | 2006 |
Oxytocin and estrogen promote rapid formation of functional GABA synapses in the adult supraoptic nucleus DT Theodosis, JJ Koksma, A Trailin, SL Langle, R Piet, JC Lodder, ... Molecular and Cellular Neuroscience 31 (4), 785-794, 2006 | 66 | 2006 |
Plasma brain‐derived neurotrophic factor as a biomarker for the main types of mild neurocognitive disorders and treatment efficacy: A preliminary study OA Levada, NV Cherednichenko, AV Trailin, AS Troyan Disease markers 2016 (1), 4095723, 2016 | 36 | 2016 |
miRNA and lncRNA as potential tissue biomarkers in hepatocellular carcinoma VR Mallela, M Rajtmajerová, A Trailin, V Liška, K Hemminki, ... Non-coding RNA research 9 (1), 24-32, 2024 | 21 | 2024 |
Theranostics nanomedicine applications for colorectal cancer and metastasis: recent advances PB Kasi, VR Mallela, F Ambrozkiewicz, A Trailin, V Liška, K Hemminki International journal of molecular sciences 24 (9), 7922, 2023 | 18 | 2023 |
Using virtual microscopy for the development of sampling strategies in quantitative histology and design‐based stereology Y Kolinko, A Malečková, P Kochová, M Grajciarová, T Blassová, T Kural, ... Anatomia, Histologia, Embryologia 51 (1), 3-22, 2022 | 18 | 2022 |
CTNNB1 mutations, TERT polymorphism and CD8+ cell densities in resected hepatocellular carcinoma are associated with longer time to recurrence F Ambrozkiewicz, A Trailin, L Červenková, R Vaclavikova, V Hanicinec, ... BMC cancer 22 (1), 884, 2022 | 15 | 2022 |
Long non-coding RNA and microRNA interplay in colorectal cancer and their effect on the tumor microenvironment M Rajtmajerová, A Trailin, V Liška, K Hemminki, F Ambrozkiewicz Cancers 14 (21), 5450, 2022 | 11 | 2022 |
P300 potential parameters at the stages of formation of the subcortical vascular dementia in elderly OA Levada, AV Trailin, AL Kvitka, OV Stolbinskaia Likars' ka Sprava, 60-66, 2014 | 11 | 2014 |
Activated hepatic stellate cells in hepatocellular carcinoma: their role as a potential target for future therapies E Ali, A Trailin, F Ambrozkiewicz, V Liška, K Hemminki International Journal of Molecular Sciences 23 (23), 15292, 2022 | 10 | 2022 |
Chronic active antibody-mediated rejection is associated with the upregulation of interstitial but not glomerular transcripts A Trailin, P Mrazova, P Hruba, L Voska, E Sticova, A Slavcev, M Novotny, ... Frontiers in Immunology 12, 729558, 2021 | 10 | 2021 |
Serum level of S100B as a marker of progression of vascular mild cognitive impairment into subcortical vascular dementia and therapy effectiveness. TAV Levada OA Lik Sprava. 2012 (3-4), 53-9., 2012 | 10 | 2012 |
T-and B-cells in the inner invasive margin of hepatocellular carcinoma after resection associate with favorable prognosis A Trailin, L Červenková, F Ambrozkiewicz, E Ali, P Kasi, R Pálek, P Hošek, ... Cancers 14 (3), 604, 2022 | 9 | 2022 |
High Serum Level of β 2-Microglobulin in Late Posttransplant Period Predicts Subsequent Decline in Kidney Allograft Function: A Preliminary Study OSN Andriy V. Trailin, Marina V. Pleten, Tatiana I. Ostapenko, Nadiia F ... Disease Markers 2015 (Article ID 562580), 10 pages, 2015 | 9* | 2015 |
Состояние NPY-синтезирующих клеток островков Лангерганса у нормальных и диабетических крыс при введении синтетического нейропептида Y МАО А.В. Траилин, Ю.М. Колесник Проблемы эндокринологии 47 (3), 36-40, 2001 | 8 | 2001 |
ИСХОДНОЕ СОСТОЯНИЕ ДОНОРСКОЙ ПОЧКИ И РИСК РАЗВИТИЯ ОТСРОЧЕННОЙ И ЗАМЕДЛЕННОЙ ФУНКЦИИ ПОЧЕЧНОГО АЛЛОТРАНСПЛАНТАТА НАС Траилин А.В., Никоненко Т.Н. Вестник трансплантологии и искусственных органов 10 (3), 13-18, 2008 | 7* | 2008 |
Molecular assessment of kidney allografts: Are we closer to a daily routine? A Trailin, P Hruba, O Viklicky Physiological Research 69 (2), 215, 2020 | 4 | 2020 |
Significance of the pathologic findings in implantation biopsies for kidney allografts survival AV Trailin, TN Nykonenko, TI Ostapenko, SR Vildanov, OS Nykonenko International Journal of Organ Transplantation Medicine 10 (1), 15, 2019 | 4 | 2019 |
Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long‐Term Allograft Function, and Patients’ Survival AV Trailin, TI Ostapenko, TN Nykonenko, SN Nesterenko, OS Nykonenko Disease Markers 2017 (1), 9264904, 2017 | 4 | 2017 |
High urinary interleukin-2 in late post-transplant period portends a risk of decline in kidney allograft function: a preliminary study AV Trailin, MV Pleten, TI Ostapenko, NF Iefimenko, OS Nykonenko BMC Research Notes 10, 1-10, 2017 | 3 | 2017 |